palpable pulses  Pertinent Results: [**2107-8-2**] 05:38AM   GLUCOSE-108* UREA N-21* CREAT-1.2 SODIUM-142 POTASSIUM-2.9* CHLORIDE-104 TOTAL CO2-28 ANION GAP-13 [**2107-8-2**] 05:38AM   ALT(SGPT)-26 AST(SGOT)-17 ALK PHOS-54 AMYLASE-71 TOT BILI-0.3 [**2107-8-2**] 05:38AM   LIPASE-29 [**2107-8-2**] 05:38AM   ALBUMIN-3.2* MAGNESIUM-2.0 [**2107-8-2**] 05:38AM   WBC-9.6 RBC-3.57* HGB-12.3* HCT-34.3* MCV-96 MCH-34.4* MCHC-35.8* RDW-14.1 [**2107-8-2**] 05:38AM   PLT COUNT-113* [**2107-8-2**] 05:38AM   PT-11.0 PTT-23.7 INR(PT)-0.9 [**2107-8-1**] 07:30PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG  RADIOLOGY   Preliminary Report  CTA CHEST W&W/O C&RECONS, NON-CORONARY  [**2107-8-2**] 2:04 PM  CTA CHEST W&W/O C&RECONS, NON-; CT PELVIS W&W/O C  Reason: Evaluation of thoracic aorta.
TECHNIQUE: Continuous axial images of the chest were obtained without IV contrast.
Following the administration of IV Optiray contrast images of the chest, abdomen and pelvis were obtained with multiplanar images also reformatted.
Scattered retroperitoneal nodes do not meet CT criteria for enlargement.
DR. [**First Name (STitle) **] [**Doctor Last Name **]  RADIOLOGY  Final Report  CTU (ABD/PEL) W/CONTRAST  [**2107-8-1**] 7:35 PM  CTA CHEST W&W/O C&RECONS, NON-; CTU (ABD/PEL) W/CONTRAST  Reason: eval dissection Field of view: 40 Contrast: OPTIRAY  [**Hospital 93**] MEDICAL CONDITION: 77 year old man with chest pain radiating to back REASON FOR THIS EXAMINATION: eval dissection CONTRAINDICATIONS for IV CONTRAST: None.
Artifact from left-sided central venous catheter and pacemaker leads is noted along with mild coronary artery calcification.
CT OF THE ABDOMEN WITH INTRAVENOUS CONTRAST: The liver, gallbladder, spleen, stomach, intra-abdominal bowel, pancreas, and adrenal glands appear unremarkable.
Both kidneys appear slightly atrophic with bilateral hypoattenuating lesions, too small to definitively characterize but likely representing simple cyst.
He was initially controlled w/Nicardipine infusion, this was transitioned to and increased oral calcium channel blocker dose and the addition of an ACE inhibitor to his existing oral regime.
He was seen by CT surgery as well as vascular surgery during this admission.
He was scheduled to return on Friday [**8-5**] for endovascular stenting w/Dr [**Last Name (STitle) 914**].
Medications on Admission: Sotolol 120" Synthroid 75' Norvasc 5' Buproprion 75' Albuterol-prn Nabumetone 750" ASA 81' Allopurinol 300' Doxazosin 8' Ultram 50-prn  Discharge Medications: 1.
Sotalol 80 mg Tablet Sig: 1.5 Tablets PO BID (2 times a day).
Levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Bupropion 75 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Allopurinol 300 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Doxazosin 4 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime).
Tramadol 50 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed.
Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*30 Tablet(s)* Refills:*0*   Discharge Disposition: Home  Discharge Diagnosis: Ulcerated descending Aorta plaque w/aortic thrombus PMH: HTN, CRI, BPH, Atrial tachyarrththymias s/p ablation/PPM, GERD, Depression, Hypothyroid, h/o PE '[**02**], gout, Rt shoulder replacement   Discharge Condition: good   Discharge Instructions: Take all medications as prescribed.
Return to preop anesthesia area Friday [**8-5**] for endovascular stenting  Followup Instructions: neck CTA [**8-4**] 3:30P [**Hospital Unit Name **] Preop holding area [**8-5**] 6A Clinical center    Completed by:[**2107-8-2**
